nanostilbene

**NanoStilbene** is a proprietary nanoemulsion formulation of nanoparticle pterostilbene, a stilbene derivative related to resveratrol, with particle sizes in the 75-90 nm range at a concentration of 200 mg/mL. Pterostilbene acts as a potent antioxidant and anti-inflammatory agent, exhibiting enhanced bioavailability due to its nanoformulation. Developed by Therapeutic Solutions International, it is positioned as a nutraceutical that augments chemotherapy efficacy (e.g., with cyclophosphamide), immunotherapy (e.g., with Yervoy in breast cancer models), and shows potential in addressing chemotherapy-induced neutropenia, microglial activation inhibition via NeuroStilbene variant, and cancer suppression. Available in topical cream form (20 mg/mL).[3][5][7][8][9][11]

Brand names

NanoStilbeneNanoStilbene™

Other names

nanoparticle pterostilbene